Dominantly inherited micro-satellite instable cancer – the four Lynch syndromes - an EHTG, PLSD position statement
Pål Møller(Unknown), Emma J. Crosbie(University of Manchester), Leandro Apolinário da Silva(Hospital de Câncer de Pernambuco), Mev Dominguez–Valentin(Norwegian Cancer Society), Rodney J. Scott(New South Wales Department of Health), Gabriela Möslein(Bethesda Hospital), Annika Lindblom(Karolinska University Hospital), Stefan Aretz(University of Bonn), Toni T. Seppälä(University of Helsinki), Karl Heinimann(University Hospital of Basel), John Burn(Newcastle University), Sigve Nakken(Oslo University Hospital), Giulia Martina Cavestro(University of Parma), Christoph Engel(University Hospital Leipzig), Neil Ryan(University of Edinburgh), Lucio Bertario(European Institute of Oncology), Julian R. Sampson(Cardiff University), Norma Rossi(University of St Andrews), Elizabeth Half(Rambam Health Care Campus), Luigi Laghi(Humanitas University), Kevin Monahan(St. Mark's Hospital), Elke Holinski‐Feder(Garvan Institute of Medical Research), Leonardo S. Lino‐Silva(Tecnológico de Monterrey), Vincent Heuveline(Heidelberg University), Karoline Horisberger(University of Vermont), Jukka‐Pekka Mecklin(University of Jyväskylä), Inge Bernstein(Aalborg University Hospital), Naim Abu‐Freha(University of Vermont), Robert Fruscio(Azienda Ospedaliera San Gerardo), Laura E. Thomas(DMG Mori (United Kingdom)), Lone Sunde(Aalborg University Hospital), Aysel Ahadova(Heidelberg University), Ingrid Winship, Sanne W. ten Broeke(Leiden University Medical Center), Bernardo Bonanni(European Institute of Oncology), Matthias Kloor(Heidelberg University), Rolf H. Sijmons(University Medical Center Groningen), Tadeusz Dębniak(International Hereditary Cancer Center), Eivind Hovig(Oslo University Hospital), Adriana Della Valle(Hospital Central de las Fuerzas Armadas), D. Gareth Evans(Manchester Academic Health Science Centre), Carlos Vaccaro(Hospital Italiano de Buenos Aires), Ivana Lúcia de Oliveira Nascimento(Instituto de Saúde), Peter Bauerfeind(Hirslanden Klinik St. Anna), Saskia Haupt(Heidelberg University), Maria Grazia Tibiletti(University of Insubria)
Cited by 48
Related Papers
Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 Studies
|The American Journal of Human Genetics|2003|3.7k
Mutation of a <i>mutL</i> Homolog in Hereditary Colon Cancer
|Science|1994|1.8k
Association analysis identifies 65 new breast cancer risk loci
|Nature|2017|1.6k